The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of intraperitoneal docetaxel plus capecitabine/cisplatin for gastric cancer with peritoneal metastasis: XP+IP DOC trial.
 
Ryoji Fukushima
Research Funding - Chugai Pharma (Inst); Lilly Japan (Inst); Nutrisystem (Inst); Taiho Pharmaceutical (Inst)
 
Hironori Ishigami
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Hiroto Miwa
No Relationships to Disclose
 
Motohiro Imano
No Relationships to Disclose
 
Daisuke Kobayashi
No Relationships to Disclose
 
Yasushi Tsuji
No Relationships to Disclose
 
Akio Hidemura
No Relationships to Disclose
 
Tetsuya Kusumoto
No Relationships to Disclose
 
Takeshi Omori
No Relationships to Disclose
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Norifumi Ohashi
No Relationships to Disclose
 
Mitsuhiko Ota
No Relationships to Disclose
 
Hironori Yamaguchi
No Relationships to Disclose
 
Joji Kitayama
No Relationships to Disclose